Oculorespiratory syndrome
Committee reports
Related links
- An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Statement on influenza vaccination for the 2002-2003 season: update on oculo-respiratory syndrome in association with influenza vaccination. Can Commun Dis Rep. 28:1-8, 2002
- An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement for the 2001-2002 season: influenza vaccination of persons who experienced oculo-respiratory syndrome following previous influenza vaccination. Can Commun Dis Rep.27:1-7,2001
(Notice to readers: Links to documents published since the initial GACVS review may contain information not considered in the above statement formulated in December 2002).
References
- Boulianne N, De Serres G, Duval B, Shadmani R, Rochette L. Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada. Can Commun Dis Rep. 31(21):217-225, 2005
- Grenier JL, Toth E, De Serres G, Menard S, Roussel R, Tremblay M, Landry M, Robert Y, Skowronski DM. Safety of revaccination of patients affected by the oculo-respiratory syndrome (ORS) following influenza vaccination. Can Commun Dis Rep.30(2):9-16, 2004
Page last updated: 14 July 2006
Page last reviewed: 3 December 2010
| Good information practices for vaccine safety web sites |
Contact us:
Global Advisory Committee on Vaccine Safety
World Health Organization (WHO)
20 Avenue Appia
1211 Geneva 27
Switzerland
Global Advisory Committee on Vaccine Safety
World Health Organization (WHO)
20 Avenue Appia
1211 Geneva 27
Switzerland